Hi-Tech Pharmacal (HITK) reported first quarter EPS of $0.67 Wednesday morning, down from $0.73 in the prior year period. The consensus estimate was for EPS of $0.51.
Hi-Tech Pharmacal gapped up Wednesday and is now trading higher by 1.31 at $19.67. The stock has broken out to a month and a half high and has also re-crossed its 50-day moving average.
For comments and feedback: editorial@rttnews.com